Geoffrey Joyce

University of Southern California — United States

Economics, Econometrics and Finance · Social Sciences

39h-index6.6kcitations174works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Economics and Policy(45), Healthcare Policy and Management(43), Health Systems, Economic Evaluations, Quality of Life(42), Medication Adherence and Compliance(31), Pharmaceutical Practices and Patient Outcomes(22)

Publications174 total

Disaggregating medical costs due to dementia
Alzheimer s & Dementia·2025Open Access
Opportunities for using the USCDM for impact
Alzheimer s & Dementia·2025Open Access
Costs of dementia: Comprehensive Estimates from U.S. Cost of Dementia Model (USCDM)
Alzheimer s & Dementia·2025Open Access
Impact of dementia caregiving on the labor force participation and lifetime earning of middle age adults
Alzheimer s & Dementia·2025Open Access
Formulary Restrictions and Relapse Episodes in Persons With Relapsing-Remitting Multiple Sclerosis
JAMA Network Open·2025· 1 citedOpen Access
Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons With Dementia
Neurology·2025· 1 citedOpen Access
The cost of misaligned incentives in the pharmaceutical supply chain
Health Affairs Scholar·2025Open Access
After Risk-Adjustment Change, Dementia Diagnoses Increased In Medicare Advantage Relative To Traditional Medicare
Health Affairs·2025· 1 cited
Changes to Medicare Advantage Risk Adjustment and Dementia Diagnosis in Older Adults
Alzheimer s & Dementia·2024Open Access
Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation
Neurology·2024· 2 citedOpen Access
P6 The Effect of Formulary Restrictions on the Disease Outcomes Among Medicare Beneficiaries With Multiple Sclerosis in the United States
Value in Health·2024Open Access
Diagnoses and Treatment of Behavioral and Psychological Symptoms of Dementia Among Racially and Ethnically Diverse Persons Living with Dementia
Journal of Alzheimer s Disease·2024· 3 cited
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011–20
Health Affairs·2024· 8 cited
Trends in Incident Dementia Diagnosis Before and After Medicare Risk Adjustment
JAMA Network Open·2023· 4 citedOpen Access
Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in Traditional Medicare and Medicare Advantage
Alzheimer s & Dementia·2023· 3 citedOpen Access
Why higher copayments for opioids did not reduce use among Medicare beneficiaries
Health Economics·2023Open Access
Blame capitalism? Why hundreds of decades-old yet vital drugs are nearly impossible to find
2023
Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·2023· 29 citedOpen Access
Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia
Journal of Alzheimer s Disease·2023· 11 cited
Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, Drug Manufacturers, and the Federal Government
Journal of Health Politics Policy and Law·2022Open Access
page 1 of 9Next →

Frequent Co-authors

Dana P. Goldman(22), Matt P. Wise(9), Julie Zissimopoulos(7), Christopher S. Saigal(5), Douglas Barthold(5), Arleen Leibowitz(4), Baoping Shang(4), Jayanta Bhattacharya(4), Michael D. Hurd(4), Darius Lakdawalla(4), Constantijn Panis(4), Sally C. Morton(3), Mark S. Litwin(3), Rodger Madison(3), Pinar Karaca‐Mandic(3), Patricia Ferido(3), Emmett B. Keeler(3), Kitty S. Chan(3), Yuhui Zheng(2), Samuel A. Bozzette(2)